RESEARCH & DEVELOPMENT-BioRay

w66国际·利来(中国)最给力的老牌

2020 官网升级中！现在您访问官网的浏览器设备分辨率宽度低于1280px
请使用高分辨率宽度访问。

RESEARCH & DEVELOPMENT

As a pioneer in China’s biopharmaceutical industry, we have deep expertise in discovering, developing, manufacturing antibody-based therapies

Scrllo Down

HOME R&D

Antibody Discovery

Our Platform

• Established phage display libraries
• Affinity maturation of human antibodies
Cell Line Development

Our Platform

• Vector design & engineering
• Established mammalian recombinant protein expression systems
New mAb Technologies

Our Platform

• Antibody-drug conjugates platform
• New mAb and fusion protein engineering
• Bi-specific and tri-specific mAb platform
Analytics

Our Platform

• In house protein analytics/characterization suite to support process development
CMC Development and GMP Manufacturing

Our Platform

• Proprietary serum-free culture medium
• Robust PC/PV development platform
• In house developability analysis & formulation development
Commercial Manufacturing

Our Platform

• 8 x 2250L mammalian bioreactors and purification suite in operation
• Leading production capability in China with new plants in planning for 2022

To Learn More

TO TOP